Your Health. Your Family. Your Choice.
|History of Changes from the VAERS Wayback Machine|
|Vaccination / Manufacturer||Lot / Dose||Site / Route|
|COVID19: COVID19 (COVID19 (JANSSEN)) / JANSSEN||1805020 / 1||- / IM|
Administered by: Private Purchased by: ??
Symptoms: Blood gases normal, Blood lactic acid normal, Blood magnesium normal, Dyspnoea, Full blood count normal, Guillain-Barre syndrome, Intensive care, Muscular weakness, Mobility decreased, Urine analysis normal, Metabolic function test, Endotracheal intubation, Influenza virus test negative, Computerised tomogram head normal, SARS-CoV-2 test negative
Life Threatening? No
Birth Defect? No
Permanent Disability? No
Office Visit (V2.0)? No
ER or Office Visit (V1.0)? No
ER or ED Visit (V2.0)? Yes
Hospitalized? Yes, days:
Write-up: Guillain Barre suspected Area Hospital Admitted Admit date: 06/27/2021 Admitting Diagnosis: Worsening generalized weakness-secondary to possible Guillian Barr? Syndrome History of Present Illness: This is a 34-year-old female patient that presented at sells emergency department with a medical history of recent upper respiratory infection, obesity, asthma who stated she is short of breath. She has generalized muscular weakness x3 days and per mother''s report, the patient was unable to get out of bed and required max assist. The patient had a CT of the head, influenza swab, COVID-19 swab, CBC, CMP, magnesium level, lactic acid, venous blood gas and urinalysis. All imaging and diagnostic lab work were negative and within normal limits. Due to worsening weakness, the ED provider in hospital intubated the patient for transfer to Hospital ICU for further evaluation and treatment.
Copyright © 2021 National Vaccine Information Center. All rights reserved.
21525 Ridgetop Circle, Suite 100, Sterling, VA 20166